BSEBoard Meeting5d ago · 5 Nov 2026, 04:45 pm
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results for the Quarter ended September 30, 2026.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryResults
Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/11/2026 to consider and approve Unaudited Standalone Financial Results for the Quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2026.